— Know what they know.
Not Investment Advice

TELA NASDAQ

TELA Bio, Inc.
1W: -6.8% 1M: +47.7% 3M: +28.6% YTD: -19.1% 1Y: -30.6% 3Y: -90.3% 5Y: -92.6%
$0.89
-0.03 (-3.51%)
 
Weekly Expected Move ±18.7%
$1 $1 $1 $1 $1
NASDAQ · Healthcare · Medical - Devices · Alpha Radar Buy · Power 58 · $39.8M mcap · 33M float · 0.562% daily turnover · Short 23% of daily vol
Smart Money Score
Watch 25
Insider
Congress
ETF Holdings
Key Statistics
Market Cap$39.8M
52W Range0.501-2.2
Volume95,661
Avg Volume182,950
Beta1.30
Dividend
Analyst Ratings
7 Buy 1 Hold 0 Sell
Consensus Buy
Company Info
CEOAntony Koblish
Employees209
SectorHealthcare
IndustryMedical - Devices
IPO Date2019-11-08
1 Great Valley Parkway
Malvern, PA 19355
US
484 320 2930
About TELA Bio, Inc.

TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. It provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene fiber intended to be used in laparoscopic and robotic-assisted hernia surgical repairs. The company markets its products through a single direct sales force, principally in the United States. TELA Bio, Inc. was incorporated in 2012 and is headquartered in Malvern, Pennsylvania.

Recent Insider Trades

NameTypeSharesPriceDate
Langstein Howard N. 0 2026-03-01
Langstein Howard N. 72,750 $0.78 2026-03-01
KOBLISH ANTONY F-InKind 3,900 $0.79 2026-02-24
KOBLISH ANTONY F-InKind 11,631 $0.77 2026-02-23
Firestone Gregory A. F-InKind 1,352 $0.77 2026-02-23

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms